Piketty Christophe, Darragh Teresa M, Heard Isabelle, Da Costa Maria, Bruneval Patrick, Kazatchkine Michel D, Palefsky Joel M
Department of Immunology, INSERM U 430 and Université Pierre et Marie Curie, Hôpital Européen Georges Pompidou, Paris, France.
Sex Transm Dis. 2004 Feb;31(2):96-9. doi: 10.1097/01.OLQ.0000109515.75864.2B.
The impact of highly active antiretroviral therapy (HAART) on the natural history of HPV infection and anal squamous intraepithelial lesions (SIL) in HIV-infected men who have sex with men (MSM) is poorly documented. GOAL The goal of this study was to evaluate the prevalence of anal HPV infection and SIL inpatients under HAART.
Forty-five HIV-infected protease inhibitor-experienced MSM were enrolled in a cross-sectional study. Each patient provided anal samples for anal cytology, histology, and human papillomavirus (HPV) DNA testing.
The patients had previously received HAART for a median of 32 months. Anal cytology was abnormal in 32 of 45 (71%) patients, including high-grade SIL in 10 patients (22%), low-grade SIL in 19 patients (42%), and atypical squamous cells of undetermined significance in 3 patients (7%). HPV DNA was detected 36/45 men (80%). The prevalence of anal SIL and HPV infection were similar in patients exhibiting a significant increase in CD4+ cell count after HAART initiation compared with those who did not.
Our results demonstrate a high prevalence of anal SIL, including high-grade SIL, and anal HPV infection in HIV-infected MSM despite immune restoration under HAART.
高效抗逆转录病毒疗法(HAART)对男男性行为者(MSM)中人类乳头瘤病毒(HPV)感染及肛门鳞状上皮内病变(SIL)自然史的影响鲜有文献记载。目标:本研究的目的是评估接受HAART治疗的患者中肛门HPV感染及SIL的患病率。
45名有蛋白酶抑制剂治疗经验的HIV感染男男性行为者纳入一项横断面研究。每位患者均提供肛门样本用于肛门细胞学、组织学及人乳头瘤病毒(HPV)DNA检测。
患者此前接受HAART治疗的中位时间为32个月。45名患者中有32名(71%)肛门细胞学检查异常,其中10名患者(22%)为高级别SIL,19名患者(42%)为低级别SIL,3名患者(7%)为意义不明确的非典型鳞状细胞。45名男性中有36名(80%)检测到HPV DNA。HAART治疗开始后CD4+细胞计数显著增加的患者与未增加的患者相比,肛门SIL和HPV感染的患病率相似。
我们的结果表明,尽管在HAART治疗下免疫功能得以恢复,但HIV感染的男男性行为者中肛门SIL(包括高级别SIL)和肛门HPV感染的患病率仍很高。